Theseus Pharmaceuticals, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis, Voyager To Focus First On Hun

It’s understandable when a company running on fumes takes action to make its dwindling finances last while fundraising conditions are difficult. But when a company with a long cash runway implements l

Despite Roche Holding AG ’s troubled investment trying to compete with Pfizer Inc. in a genetically defined subpopulation of non-small cell lung cancer, Bristol Myers Squibb Company has decided t

Pyxis Oncology , Theseus Pharmaceuticals, Inc. and Cognition Therapeutics, Inc. launched initial public offerings in the US between 6 and 8 October, raising $373.2m combined, but the first three c